C-N Gann1, N Morsli2, R Kaiser3. Show Affiliations » 1. Boehringer Ingelheim GmbH & Co. KG, Ingelheim, Germany. 2. Boehringer Ingelheim Corporation, Reims, France. 3. Boehringer Ingelheim Pharmaceuticals GmbH & Co. KG, Biberach, Germany.
Abstract
Entities: Species
Mesh： See more » Antineoplastic Combined Chemotherapy Protocols/therapeutic useCarcinoma, Non-Small-Cell Lung/drug therapyDocetaxelDrug IndustryDrugs, InvestigationalEuropean UnionHealth Services AccessibilityHumansIndoles/administration & dosageLung Neoplasms/drug therapyNeeds AssessmentTaxoids/administration & dosage
Substances： See more » Drugs, InvestigationalIndolesTaxoidsDocetaxelnintedanib
Year: 2017 PMID： 27831504 DOI： 10.1093/annonc/mdw569
Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976